Cytomegalovirus Infections
Welcome,         Profile    Billing    Logout  
 14 Companies   16 Products   16 Products   24 Mechanisms of Action   3 Trials   179 News 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cytomegalovirus Infections
NCT00547235: Emergency Use of Adoptive Immunotherapy With CMV-Specific T Cells After Donor Bone Marrow Transplant of an Infant With Immunodeficiency Syndrome and CMV Infection

No Longer Available
N/A
US
therapeutic allogeneic lymphocytes, allogeneic bone marrow transplantation, total-body irradiation
Fred Hutchinson Cancer Center, National Cancer Institute (NCI)
Infection, Precancerous/Nonmalignant Condition
12/12
 
EAP CHALLAH, NCT01945619: Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT

No Longer Available
N/A
US
Trivirus-Specific CTLs
Baylor College of Medicine, Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital Research Institute, Children's Hospital Los Angeles, Duke University, Hackensack Meridian Health, New York Medical College, University of Texas Southwestern Medical Center, Children's National Research Institute, Johns Hopkins All Children's Hospital
EBV Infection, CMV Infection, Adenoviral Infection
 
 
NCT03010332: Expanded Access Protocol of ATA230 (Third-Party Donor-Derived CMV-CTLs) for the Treatment of CMV Viremia or Disease

No Longer Available
N/A
NA
Cytomegalovirus-specific Cytotoxic T Lymphocytes (CMV-CTLs), ATA230
Atara Biotherapeutics
CMV Viremia, CMV Disease
 
 

Download Options